Sean E. Browne - Aug 15, 2024 Form 4 Insider Report for Xtant Medical Holdings, Inc. (XTNT)

Role: President and CEO, Director
Signature: /s/ Amy E. Culbert, attorney-in-fact
Stock symbol: XTNT
Transactions as of: Aug 15, 2024
Transactions value $: -$6,364
Form type: 4
Date filed: 8/19/2024, 04:09 PM
Previous filing: Apr 5, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	XTNT	Common Stock	Tax liability	-$6.36K	-10.6K	-0.46%	$0.60	2.3M	Aug 15, 2024	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards.
F2	Includes an aggregate of 862,294 shares issuable upon vesting and settlement of restricted stock unit awards or deferred stock unit awards granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 433,024 shares issuable upon vesting and settlement of restricted stock unit awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, in each case conditioned upon the Reporting Person remaining an employee of Xtant through the respective vesting dates.

Content

These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards.

Includes an aggregate of 862,294 shares issuable upon vesting and settlement of restricted stock unit awards or deferred stock unit awards granted under the Xtant Medical Holdings, Inc. 2023 Equity Incentive Plan and 433,024 shares issuable upon vesting and settlement of restricted stock unit awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, in each case conditioned upon the Reporting Person remaining an employee of Xtant through the respective vesting dates.